AUSTRALIAN AND NEW ZEALAND POLYCYSTIC KIDNEY DISEASE (ANZ-PKD) SCIENTIFIC MEETING:
WEBINAR 2 SURVEY

We would appreciate your feedback on the webinar to help us continue to provide relevant and high quality education.

Your responses will be anonymous unless you choose to submit your name and email address.

Question Title

* 1. Overall, how would you rate the webinar?  
(Scale of 1 to 10, with 10 being highest and 1 being lowest)

Question Title

* 2. Please rate your understanding of cardiovascular disease and PKD PRIOR to the webinar.  
(Scale of 1 to 10, with 10 being highest and 1 being lowest)

Question Title

* 3. Please rate your understanding of cardiovascular disease and PKD AFTER the webinar.  
(Scale of 1 to 10, with 10 being highest and 1 being lowest)

Question Title

* 4. What was the most important take-away for you?

Question Title

* 5. Do you have any further questions for the speakers, suggestions for future topics or any other feedback?

Question Title

* 6. If you have questions for the speakers in Question 5 above, please provide your name and email address so that they can respond to you.

Please ensure you hit the "Send Response" button at the bottom of the page.

Privacy Statement: At Otsuka Australia Pharmaceutical Pty Ltd we comply with the National Privacy Principles. We may collect and store your personal information for the purposes of collating responses to the forms, emails and other correspondence related to the webinar, which may include disclosure to program sponsors, or third parties for the purpose of processing and collating the information. This information will be used and disclosed only in accordance with our Privacy Policy and not for any other purpose unless required to do so by law. By completing this form you consent to the use of your information in this manner.

Question Title

This meeting is sponsored by Otsuka Australia Pharmaceutical Pty Ltd.
The content of this meeting, including the selection of speakers, is developed independently by a Steering Committee, with no input from Otsuka.
Otsuka Australia Pharmaceutical Pty Ltd, ABN 20 601 768 754.
Chatswood, NSW 2067. Date of preparation: May 2021. JIN-2105-40.00

<strong><span style="font-size: 8pt;">This meeting is sponsored by Otsuka Australia Pharmaceutical Pty Ltd.<br>The content of this meeting, including the selection of speakers, is developed independently by a Steering Committee, with no input from Otsuka.</span></strong><br><span style="font-size: 8pt;">Otsuka Australia Pharmaceutical Pty Ltd, ABN 20 601 768 754.</span><br><span style="font-size: 8pt;">Chatswood, NSW 2067. Date of preparation: May 2021. JIN-2105-40.00</span>

T